Axial Therapeutics
Clinical-stage CNS bio-pharmaceutical company focused on small molecule therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD230—345m (Dealroom.co estimates Oct 2021.)
Waltham Massachusetts (HQ)
Authorizing premium user...